← All trials
NCT05385783
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2022
- Primary completion
- Jul 23, 2023
- Completion date
- Jul 23, 2023
- First posted
- May 23, 2022
- Last posted
- Jul 13, 2022
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cybin Therapeutics Inc.Lead sponsor
- ClinilabsCollaborator
- Cybin Therapeutics Inc.Study director
- Cybin Therapeutics Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.